MedPath

Clinical Evaluation of GRAPE Model for Gastric Cancer Screening

Recruiting
Conditions
Gastric Cancer
Registration Number
NCT07067983
Lead Sponsor
Zhejiang Cancer Hospital
Brief Summary

A Prospective Study Evaluating the Performance of the GRAPE Model in Gastric Cancer Screening and Its Detection Rates Across Different Disease Stages

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000000
Inclusion Criteria
  • Aged between 18 and 80 years
  • Individuals undergoing thoracoabdominal CT examination
  • Voluntarily participated in the study and provided written informed consent
Exclusion Criteria
  • Patients with confirmed diagnosis of gastric cancer
  • Individuals with severe intellectual disabilities or communication disorders

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
GRAPE systematic screening resultsfirst visited at baseline

Screen-positive individuals after GRAPE systematic screening

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)

🇨🇳

Hangzhou, Zhejiang, China

Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
🇨🇳Hangzhou, Zhejiang, China
Xiangdong Cheng, PhD.
Contact
+0086-0571-88128041
chengxd516@126.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.